Sponsored Symposia 2022

Tuesday, November 22, 2022

10:45-11:15 am

Flash Talk I

Supported by Promega

Novel Bioluminescent Bioassays for the Discovery and Development of Molecular and Cellular T Cell Redirecting Therapy
Johann, Axel

11:30 am – 12:15 pm

Industry sponsored session I 

Supported by Gilead

Welcome and introduction: Recent developments in CAR T cell therapy
Chair: Vucinic, Vladan (Universitätsklinikum Leipzig)

CAR T cell therapy in the treatment of relapsed/refractory NHL
Schnetzke, Ulf (Universitätsklinikum Jena)

CAR T cell therapy in the treatment of relapsed/refractory adult B-ALL
Bug, Gesine (Universitätsklinikum Frankfurt)

Panel discussion and Q&A: Patient selection, patient management and CAR T patient journey
Chair: Vucinic, Vladan (Universitätsklinikum Leipzig)

1:00-1:45 pm

Industry sponsored session II

Supported by Janssen-Cilag

Chair: Raab, Marc-Steffen (Heidelberg)

Sequence therapy after BCMA pre-therapy, integration into the overall therapy of multiple myeloma
Raab, Marc-Steffen (Heidelberg)
Kortüm, Martin (Würzburg)

 

 

Wednesday, November 23, 2022

10:45-11:15 am

Flash Talk II

Supported by Amgen

T cell engaging therapies in the treatment of Acute Lymphoblastic Leukemia (ALL)
Gökbuget, Nicola (University Hospital Frankfurt, Frankfurt, Germany)

1:00-1:45 pm

Industry sponsored session III

Supported by Bristol Myers Squibb

CAR-T-Cell therapies: personalized cancer medicine 2.0
Scheid, Christoph (Universitätsklinikum Köln)
Glaß, Bertram (Helios Klinikum Buch)